Treatment for<unk>  depends on the evident phase of the disorder. Because the symptoms of<unk>  are similar (or perhaps identical) to those of the disease well-identified as "abdominal migraine," prophylactic migraine medications, such as topiramate and amitriptyline, have seen recent success in treatment for the prodrome and vomiting phases, reducing the duration, severity, and frequency of episodes. Therapeutic treatment for the prodromal phase, characterized by the anticipation of an episode, consists of sumatriptan (nasal or oral) an anti-migraine medication, anti-inflammatory drugs to reduce abdominal pain, and possible anti-emetic drugs. These options may be helpful in preventing an episode or reducing the severity of an attack. The most common therapeutic strategies for those already in the vomiting phase are maintenance of salt balance by appropriate intravenous fluids and, in some cases, sedation. Having vomited for a long period prior to attending a hospital, patients are typically severely dehydrated. For a number of patients, potent anti-emetic drugs such as ondansetron (Zofran) or granisetron (Kytril), and dronabinol (Marinol) may be helpful in either preventing an attack, aborting an attack, or reducing the severity of an attack. Many patients seek comfort during episodes by taking prolonged showers and baths typically quite hot. The use of a heating pad may also help reduce abdominal pain. Lifestyle changes may be recommended, such as extended rest, reduction of stress, frequent small meals, abstain from fasting, and possibly cessation of cannabis use. A diet change may be recommended avoid food allergens, eliminating trigger foods such as chocolates, cheese, beer, and red wine. Some patients experience relief from inhaled isopropyl alcohol.
Cyclic vomiting syndrome
Cannabinoid hyperemesis syndrome
Ichthyoallyeinotoxism
Geophagia
Bloom syndrome
Aerophagia
Jamaican vomiting sickness
Mallory–Weiss syndrome